Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review

Multiple sclerosis (MS) is the most common chronic autoimmune disease of the central nervous system. Efficacy of treatments for MS is associated with risk of adverse effects, and effective and well-tolerated drugs remain a major unmet need. Cannabis (Cannabis sativa L., fam. Cannabaceae) and cannabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Furgiuele, Alessia, Cosentino, Marco, Ferrari, Marco, Marino, Franca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829325/
https://www.ncbi.nlm.nih.gov/pubmed/33492630
http://dx.doi.org/10.1007/s11481-021-09982-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829325/
https://www.ncbi.nlm.nih.gov/pubmed/33492630
http://dx.doi.org/10.1007/s11481-021-09982-7

Ejemplares similares